BioLife Plasma Services
The Head of Validation & Risk Management leads Takeda’s global process validation and risk management function, setting enterprise strategy and standards for qualification, validation, and lifecycle maintenance across internal sites and external partners. This role serves as the senior validation technical authority for health authorities and governance forums while building and leading a global team of validation subject matter experts. The position is responsible for defining global validation strategies, standards, and risk management methodologies to ensure a consistent, science-based approach across all manufacturing operations.
Headquarters
Bannockburn, Illinois, United States
Company Size
5001-10000 employees
BioLife Plasma Services operates a network of plasma collection centers that collect donated human plasma used to manufacture life‑saving plasma‑derived therapies. The company focuses on donor safety and convenience, offering screening, regulated collection procedures, appointment scheduling, and compensation/rewards to encourage repeat donations. BioLife partners with biopharmaceutical manufacturers and maintains rigorous quality and regulatory standards to supply plasma for treatments such as immune deficiencies, bleeding disorders, and other therapeutic uses.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioLife Plasma Services.
Head of Validation & Risk Management
Takeda Pharmaceuticals Korea Co., Ltd.
Ingénieur en Validation de Procédés - Biotech
agap2
Ingénieur en Validation de Procédés - Biotech
agap2
Ingénieur en Validation de Procédés - Biotech
agap2
Trainee MSAT Validation / MSAT Process Expert
WayUp
Ingénieur en Validation de Procédés - Biotech
agap2